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A B S T R A C T   
Objectives: To obtain public support for the active disinvestment (i.e. policy decision to stop reimbursement) of 
healthcare interventions, it is important to have insight in what the public thinks about disinvestment and which 
considerations they find relevant in this context. Currently, evidence on relevant considerations in the disin-
vestment context is limited. Therefore, this study aimed to explore the societal views in the Netherlands on the 
active disinvestment of healthcare interventions and obtain insight into the considerations that are relevant for 
those holding the different views. 
Methods: A Q-methodology study was conducted among a purposively selected sample of citizens (n = 43). Data 
were collected in June and July 2019. Participants individually ranked a set of 43 statements broadly covering 
the issues that participants could consider relevant in the disinvestment context, from ‘least agree’ to ‘most 
agree’. Qualitative feedback on the statement ranking was collected from each participant using a questionnaire. 
Principal component analysis followed by oblimin rotation was used to identify clusters of participants with 
similar statement rankings. These clusters/factors were interpreted as distinct viewpoints using the factor arrays 
and qualitative questionnaire responses of participants. 
Results: Four viewpoints were identified. People holding viewpoint I believe that reimbursement of necessary 
healthcare should be maintained, irrespective of its costs. People holding viewpoint II agree with viewpoint I, 
although they believe that necessity should be objectively determined. People holding viewpoint III think that 
unnecessary, ineffective and inefficient healthcare should be disinvested. People holding viewpoint IV, consider 
it most important that disinvestment decision-making processes are transparent and consistent. 
Conclusion: Insight in the distinct viewpoints identified in this study contributes to a better understanding of why 
it has been considered difficult to obtain public support for disinvestment of healthcare interventions, and can 
help policymakers to change their approach to disinvestment to increase public support.   
1. Introduction 
The continuing rise in healthcare expenditure in OECD countries 
(Organisation for Economic Co-operation and Development, 2019), has 
put increasing pressure on public financing of healthcare (de la Mai-
sonneuve and Martins, 2015; van der Horst et al., 2011). To curb the 
growth in healthcare expenditure, policymakers have increasingly been 
considering disinvestment of healthcare interventions as a policy option 
(Calabro et al., 2018; Daniels et al., 2018). Two types of disinvestment 
can be discerned: 1) passive disinvestment, which is not dependent on 
any direct intervention by policymakers, but mainly results from 
changing practices of healthcare providers or withdrawal from the 
market by the manufacturer, and 2) active disinvestment, which is the 
full withdrawal, retraction, restriction or substitution of resources from 
certain existing healthcare interventions, as a result of policy decisions, 
affecting the accessibility of these interventions to patients (Daniels 
et al., 2013, 2018; Elshaug et al., 2007; Parkinson et al., 2015). There 
may be several reasons for the disinvestment of healthcare in-
terventions, such as harm, limited effectiveness or not enough value for 
money (Elshaug et al., 2007). Disinvestment may be the outcome of 
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Health Technology Reassessment (HTR), which is the structured, 
evidence-based assessment of healthcare interventions, currently being 
used in the healthcare system, based on their clinical, economic, social 
and ethical aspects (Leggett et al., 2012; MacKean et al., 2013). 
The disinvestment of healthcare interventions has been described in 
the international literature as very difficult (MacKean et al., 2013; 
Makady et al., 2019; Robinson et al., 2011). Even in cases where there 
was strong evidence that the intervention was not (cost-)effective, 
withdrawal of this intervention was considered a delicate issue (MacK-
ean et al., 2013). Unsurprisingly, a review of empirical evaluations of 
disinvestment initiatives from several different countries concluded that 
only a limited number of these initiatives was successful (Chambers 
et al., 2017). Support from healthcare professionals, politicians, and the 
general public has been described as essential for successful disinvest-
ment (Daniels et al., 2013; Rotteveel et al., 2021). To obtain public 
support, it is important to have insight in how the public feels about 
disinvestment and which considerations they find relevant in this 
context. Furthermore, the engagement of public preferences in disin-
vestment decisions has been described to have a range of benefits: 1) 
instrumental benefits such as improving decision outcomes, 2) demo-
cratic benefits such as citizen engagement, and 3) educational benefits 
such as raising public awareness on the complexity of disinvestment 
decisions (Daniels et al., 2018). 
However, the scientific literature on the considerations that citizens 
find relevant in the context of disinvestment is limited to two studies 
looking at disinvestment in the context of a specific intervention (i.e. 
cancer drugs and vitamin B12/folate pathology testing) and one study 
aiming to answer a specific question in the context of disinvestment (i.e. 
whether people would like to know if their care is rationed). These 
studies found that citizens consider it important that disinvestment de-
cisions are transparent (Coast, 2001) and based on clear and consistent 
principles and real-world (cost)effectiveness data (Bentley et al., 2019). 
Furthermore, the latter study also found that citizens consider it 
important not to disrupt current treatments of patients (Costa et al., 
2019). Finally, in the context of testing, Street et al. found it to be 
important to take costs, alternatives, disease severity, accuracy, poten-
tial to benefit and externalities into account in disinvestment 
decision-making (Street et al., 2015). Although these studies already 
provided some insight in the considerations that citizens find relevant in 
the context of disinvestment, it seems relevant to also investigate the 
relevant considerations for disinvestment in general, instead of in a 
specific context, to be able to improve disinvestment decision-making 
and increase public support for these decisions. Furthermore, it also 
seems relevant to assess whether views on which considerations are 
relevant differ between citizens. Therefore, in this study, we aimed to 
explore the societal views on the active disinvestment of healthcare 
interventions and to identify the considerations that people holding the 
different views consider important in this context. To this end, we have 
used Q-methodology, a method combining aspects of quantitative and 
qualitative research methods that enables the elicitation of rich, holistic 
viewpoints on a certain topic in a certain population (van Exel et al., 
2015). In this study, we focus on the active disinvestment of healthcare 
interventions, with healthcare interventions indicating a broad range of 
curative care, including medicines, therapies, surgeries, medical de-
vices, services and other types of curative care. 
We have explored the societal views on active disinvestment and 
relevant considerations in the context of the Dutch social health insur-
ance system. In the Netherlands, the coverage of the basic health in-
surance package is determined by the Minister of Health, Welfare and 
Sports based on advice from the Ministry of Health, Welfare and Sports 
and the National Healthcare Institute. In its advice, the National 
Healthcare Institute assesses healthcare interventions on four criteria: 
effectiveness, cost-effectiveness (i.e. health effects in relation to the costs 
of the intervention), necessity (i.e. do disease severity and the costs per 
patient justify coverage), and feasibility (i.e. is coverage feasible) 
(Zwaap, 2017). In policy documents, it is assumed that when a 
healthcare intervention does not meet these four criteria anymore, it will 
no longer be delivered by healthcare providers (i.e. passively dis-
invested) (Couwenbergh et al., 2013). However, in the past, also several 
decisions have been taken to (partially) stop reimbursement (i.e. active 
disinvestment) (Rotteveel et al., 2021). 
2. Methods 
2.1. Approach 
In this study, we used Q-methodology because this method fits the 
explorative nature of this study very well. Through the combination of 
qualitative and quantitative research methods, Q-methodology enabled 
us to obtain rich, holistic descriptions of the societal viewpoints on 
active disinvestment in a systematic way (van Exel et al., 2015). 
In a Q-methodology study, participants are asked to rank a 
comprehensive set of statements on a grid, according to how they feel 
about these statements (e.g. agree/disagree, important/unimportant), 
and explain the motivation behind their rankings. By-person factor 
analysis is used to identify clusters of participants with highly correlated 
rankings of the statements. The interpretation of the factors is facilitated 
by the weighted average ranking of the statements for the participants 
statistically significantly and uniquely associated with each identified 
factor, together with the qualitative data obtained from these partici-
pants, when explaining their ranking of the statements (Baker et al., 
2006; Watts and Stenner, 2012). Q-methodology has been widely 
applied in the context of health, healthcare, and healthcare priority 
setting (Honey et al., 2013; Patty et al., 2017; Stenner et al., 2003; 
Truijens and van Exel, 2019; van Exel et al., 2015). 
2.2. Statement set development 
We developed a statement set that was broadly representative for our 
topic of interest, i.e. the active disinvestment of publicly funded 
healthcare interventions, in three consecutive steps. In the first step, we 
aimed to derive a broad, comprehensive collection of considerations 
potentially relevant in the context of active disinvestment. To this end, 
we adopted the conceptual framework from a previous study in which 
stakeholders (i.e. policymakers, patients, healthcare providers and other 
stakeholders) were interviewed to obtain insight into active disinvest-
ment processes and aspects determining their outcome. This conceptual 
framework consisted of the actors, considerations and structures that 
may play a role in the different stages of a disinvestment process (Rot-
teveel et al., 2021). Subsequently, the considerations from this frame-
work were complemented by the considerations that are relevant for 
citizens as identified in three previous Dutch Q-methodology studies in 
the context of investment (Reckers-Droog et al., 2020; Wouters et al., 
2017; van Exel et al., 2015), and in the three previously published 
studies in the context of disinvestment (Bentley et al., 2019; Coast, 2001; 
Costa et al., 2019; Street et al., 2015). This resulted in a broad frame-
work containing 87 potentially relevant considerations (see Appendix 
A). 
Secondly, in an iterative process, the augmented framework was 
critically reviewed by three researchers (AR, ML, JvE) to merge dupli-
cate/comparable considerations and to discard considerations that were 
not relevant given the topic of interest. For each of the remaining con-
siderations, a statement was formulated by AR and critically reviewed 
by ML and JvE to ensure that the statements were concise and clear. This 
process resulted in a set of 45 statements. 
Thirdly, to test the comprehensiveness and clarity of the statement 
set (and the other study materials), a pilot test was conducted among a 
convenience sample (n = 6). As a result of the pilot test, the statement “If 
it is difficult to do research after the effect of the treatment, reim-
bursement may be stopped” was removed from the statements set, as 
participants did not understand why it may be difficult to do research, a 
problem we could not resolve with additional explanation or rephrasing 
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of the statement. The statement “It is important that all those involved 
should be consulted in decisions on stopping the reimbursement” was 
also removed as participants did not find this realistic. Based on the 
feedback provided by participants, we clarified the wording of six 
statements (i.e. statements 5, 10, 11, 12, 13, 18 and 34), the information 
letter, and instruction for participants. The final set of 43 statements and 
its embedding in the conceptual framework is presented in Appendix B. 
More details on statement set development (in Dutch) are available from 
the authors upon request. 
2.3. Data collection 
For efficiency reasons, data were collected in group sessions with, on 
average, seven participants each. In these sessions, held in June and July 
2019, participants were instructed to conduct the tasks individually. 
Participants were recruited through a commercial panel company. This 
panel company approached a large sample for participation in this study 
by sending them the participant information letter. Participants who 
were willing to participate in this study, could subscribe to one of the 
scheduled group sessions. The panel company controlled the enrolment 
of subscribed participants in the group sessions to ensure that the sample 
was diverse with regards to age (≥18 years), education level, political 
affiliation, and geographical spread. We used these variables as sam-
pling variables because we expected these to be predictive of people 
having different views on disinvestment, enabling us to include a pur-
posive sample. Participants of the group sessions received a show-up fee 
of €42.50 to compensate them for their time and travel expenses. The 
group sessions were led by the same researcher (AR), alternately helped 
by one of the other authors. 
Participants were recruited until data saturation was reached, that is 
when no new viewpoints emerged from the data (Saunders et al., 2018). 
Saturation was determined based on participants’ statement rankings 
and their written explanation of their ranking and their viewpoint on 
disinvestment. To ensure that we interpreted the written explanations 
right, these were checked with participants during the group sessions. In 
determining saturation, we focused on the most characterizing state-
ments of the ranking (i.e. those ranked highest and lowest) in combi-
nation with the provided explanations. This combination allowed us to 
develop a general understanding of the viewpoints of participants, 
allowing us to determine saturation before formal analysis was started. 
After obtaining written informed consent, participants received a 
short oral explanation of the task. Subsequently, participants were 
handed over a written instruction, the sorting grid (see Fig. 1), 43 
randomly numbered cards containing the statements, and a glossary 
explaining terms that participants may consider difficult (i.e. basic 
benefits package and medical guidelines). The written instruction 
described the background of the task (see Appendix C), and asked par-
ticipants to, first, read all statements and sort them into three piles (i.e. 
agree, disagree, neutral/don’t know), then, to rank the statements from 
each pile onto the sorting grid (starting with the agree pile, followed by 
the disagree pile and, lastly, the neutral/don’t know pile), and, finally, 
to check and confirm the overall ranking of the statements. After fin-
ishing the ranking exercise, participants completed a short question-
naire (see Appendix D) that asked them 1) to explain why they agreed 
most/least with the four statements placed in the outer columns of the 
sorting grid, 2) to phrase their opinion on the topic of interest in their 
own words, and 3) two questions about their current health (i.e. the EQ- 
5D-5L and the EQ-5D visual analogue scale (VAS) (Buchholz et al., 2018; 
The EuroQol Group, 1990)) because we hypothesized that participants’ 
health may affect their view on disinvestment. 
2.4. Ethics 
Ethical approval was obtained from the internal review board of the 
Erasmus School of Health Policy & Management (IRB 2019-03).Written 
informed consent was obtained from all participants at the start of the 
task. Participants were informed that participation was voluntary and 
anonymous, and that they had the possibility to retract their consent at 
any time without having to give a reason. The research team did not 
have access to participants’ contact information and handled the 
remaining participant information confidentially. 
2.5. Data analysis and interpretation 
A principal component analysis followed by oblimin rotation (a 
general form of oblique rotation (Jackson, 2005)) was conducted to 
identify clusters of participants with highly correlated statement rank-
ings. We determined the best number of factors from all possible factor 
solutions based on the following criteria: 1) Eigen Value of each factor 
>1.00; 2) a minimum of two non-confounded exemplars per factor (i.e. 
Fig. 1. Sorting grid used in this study.  
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participants whose statement ranking was statistically significantly (i.e. 
p < 0.05) and uniquely (i.e. square of factor loading > sum of square of 
the loading on other factors) associated with the factor); 3) a low or 
moderate correlation between the factors in the solution (with <0.30 
being low, between 0.30 and 0.50 being moderate, and >0.50 being 
high (Cohen, 2013)); and 4) coherence and distinctiveness of the 
interpretation of the factors as determined by the researchers (AR, VR 
and JvE). 
For all factors, a factor array was computed. Factor arrays concern an 
average ranking of the statements by participants who are statistically 
significantly and uniquely associated with the respective factor, 
weighted by their factor loadings, and represent how a hypothetical 
person with a correlation of 1.00 with that factor would have ranked the 
statements. Factor interpretation was based on the factors arrays, with 
special attention for the characterizing and distinguishing statements, 
and the qualitative questionnaire responses obtained from participants. 
Characterizing statements are those statements that are ranked the 
highest and lowest in the factor array, i.e. the statements participants 
associated with the viewpoint agreed least or most with. Distinguishing 
statements are those that have a statistically significantly different po-
sition in the factor array as compared to all other factors (p-value<0.05). 
One participant placed 11 more statements on the ‘agree side (col-
umn 6–9)’ of the fixed sorting grid than was indicated. As the participant 
confirmed the statement ranking after having been pointed to the de-
viation from the intended form and the statement ranking was sub-
stantiated by the qualitative questionnaire responses, we decided to 
retain this participant in our analysis. To be able to include this ranking 
in our analysis, we analyzed the data as a non-forced distribution. A 
sensitivity analysis excluding this participant and analyzing the data as a 
forced distribution showed that the decision to retain this participant in 
our analysis had no significant effect on the outcome of the analysis. 
The ‘qmethod’ package in Rstudio 1.2.1335 was used for the analyses 
(R Core Team, 2019; Zabala, 2014). 
For the presentation of the study and our results in this manuscript, 
all statements, all presented quotes and the study material presented in 
the appendices were translated from Dutch to English by a professional 
translation company. 
3. Results 
Based on the statement rankings and the qualitative questionnaire 
responses, we found that saturation was reached after 43 participants. 
The mean (SD) age of the participants was 48.2 (16.4) years and the 
majority was male (56%, see Table 1). Participants were well distributed 
across education levels and well spread across the Dutch political 
spectrum. Geographical spread was ensured by the conduct of data 
collection on different locations across the Netherlands. 
Based on the statistical criteria described in section 2.4, a maximum 
of four factors was supported by the data. After a first inspection, all four 
factors were retained as distinct viewpoints, as each of them had a 
coherent and clear interpretation and seemed to represent a distinct 
viewpoint on disinvestment. The factors were defined by 19, 4, 12 and 3 
participants, respectively, and Eigen Values were between 2.8 and 9.1. 
Five participants were not statistically significantly associated with one 
of the factors, because they loaded on multiple factors. Together, the 
factors explained 48% of the data variance, with 6.5%–21.1% of 
explained variance per factor. Correlations between the four factors 
were low for factors 1 and 2 (0.27), for factors 1 and 3 (0.22), for factors 
2 and 3 (0.21), and for factors 2 and 4 (0.21). Correlations were mod-
erate for factors 1 and 4 (0.34), and for factors 3 and 4 (0.45). The factor 
loadings of participants are displayed in Appendix E. 
Table 2 shows the factor arrays. The factor arrays display the 
weighted average ranking of the statements by all participants who are 
statistically significantly and uniquely associated with the factor: a score 
of +4 indicates that these participants would rank the statement in the 
most agree column of the sorting grid in Fig. 1 (column 9), a score of − 4 
indicates that these participants would rank the statement in the least 
agree column of the sorting grid (column 1), a score of 0 indicates that 
these participants would rank the statement in the middle of the sorting 
grid (column 5). A superscript c displayed alongside the score indicates 
that the ranking of this statement is distinguishing between that factor 
and all other factors. 
Below, the interpretation of the four factors as four distinct view-
points on what people consider important in disinvestment decisions is 
presented. The viewpoints are described using the characterizing and 
distinguishing statements for that factor (where # represents the state-
ment number, with the corresponding factor array score, and * indicates 
that the statement is distinguishing). Quotes selected from the qualita-
tive questionnaire responses of participants statistically significantly 
and uniquely associated with the factor (with participant ID between 
brackets) are used for illustration. These quotes were selected based on 
how well they illustrated our findings. 
Table 1 
Descriptive statistics of the participants (N = 43).    









Gender Males 24 
(56)   
Females 19 




(33)   
Middle 13 
(30)   
High 16 




(42)   
Centre 8 
(19)   
Right 14 
(33)   
Missing 1 (2)   
Other characteristics 










(23)   
Alone, but with 
children 
4 (9)   
Together with partner 14 
(33)   
Together with partner 
and children 
10 
(23)   
With parents 5 
(12)   
Children No 15 
(35)   
Yes 28 
(65)    
a SD = standard deviation. 
b Education levels correspond to the SOI 2016 and the ISCED 2011 
classifications. 
c The parties participants would vote if there would be elections now were 
categorized by the commercial panel in left, centre and right. We adopted this 
categorization to report on this variable here, as the specific party participants 
would vote is not informative for international readers. However, when check-
ing for spread across the political system, we looked at the specific parties the 
participants would vote, not the categorization as reported here. 
d Calculated from the EQ-5D-5L score using the Dutch tariff (Versteegh et al., 
2016). 
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3.1. Viewpoint I 
People holding this viewpoint consider it important that the reim-
bursement of necessary healthcare will be maintained. They believe 
healthcare is necessary if it concerns treatment for severely ill patients 
(#16, +4*; #37, +3), if a treatment is included in medical guidelines 
(#10, +2), if physicians think patients will benefit from the treatment 
(#11, +3*) and if the treatment is considered medically necessary (#15, 
Table 2 
Factor arrays.  
# Statement F1a F2a F3a F4a 
1 If the treatment is effective, reimbursement 
should not be discontinued. 
+2c +1 0 +4c 
2 If the treatment leads to small health benefits, 
reimbursement may be discontinued. 
− 3c 0 0 − 1c 
3 If the quality of life of patients is still poor after 
treatment, reimbursement of this treatment 
may be discontinued. 
− 4c +2c +0c − 2c 
4 If the quality of life of patients is good without 
the treatment, reimbursement of this treatment 
may be discontinued. 
− 1 − 1 +2 +1 
5 If there is a significant difference in the effect of 
the treatment between patients, 
reimbursement of the treatment should only be 
discontinued for patients in whom it has little 
effect. 
− 1 − 3c 0 0 
6 While it is not yet clear which patients will 
benefit from the treatment, this treatment 
should continue to be reimbursed for all 
patients. 
0 0 − 1 0 
7 If the chances of the treatment having an effect 
are small, the reimbursement may be 
discontinued. 
− 3 − 1 0 0 
8 If the effect of the treatment cannot be 
scientifically demonstrated, reimbursement for 
this treatment may be discontinued. 
− 1 − 1 +2c 0 
9 While research into the effect of the treatment 
is still ongoing, the reimbursement should not 
be discontinued 
+1c − 4c − 1c − 2c 
10 If the treatment is included in the medical 
guideline, reimbursement for this treatment 
should not be discontinued. 
+2 +1 0 0 
11 If doctors believe that patients are benefiting 
from the treatment, reimbursement should not 
be discontinued. 
+3c 0 +2 +1 
12 If patients feel they are benefiting from the 
treatment, reimbursement should not be 
discontinued. 
0c − 1 − 3c − 2 
13 If the treatment costs are high in relation to its 
effects, reimbursement may be discontinued. 
− 2c 0 +1c 0 
14 If a cheaper alternative to the treatment is 
available (which works equally well), 
reimbursement of the treatment may be 
discontinued. 
0 0 +3 +2 
15 If the treatment is medically necessary, 
reimbursement may not be discontinued. 
+4 +4c +2 +3 
16 If a serious illness is concerned, reimbursement 
for its treatment should not be discontinued. 
+4c +1 +1 − 1 
17 If a chronic illness is concerned, 
reimbursement for its treatment should not be 
discontinued. 
+2 +1 +1 +2 
18 If patients feel that the treatment is necessary, 
its reimbursement should not be discontinued. 
0c − 3 − 4c − 3 
19 If a particular complaint is part of normal life, 
reimbursement for its treatment may be 
discontinued. 
− 1 0 +4c − 4c 
20 If patients can pay for the treatment 
themselves, reimbursement for this treatment 
may be discontinued. 
− 2c +2c − 1c − 4c 
21 If the patient is personally responsible for 
developing a condition, reimbursement for its 
treatment may be discontinued. 
− 2 − 2 0c − 2 
22 If the treatment is frequently used just because 
it is reimbursed, reimbursement may be 
discontinued. 
− 1c 0 +4c +2 
23 If the treatment helps patients to maintain their 
dignity, reimbursement should not be 
discontinued. 
0 − 2 − 1 0 
24 If the treatment is the only treatment option for 
a condition, its reimbursement should not be 
discontinued. 
+3 +4 +1 +2 
25 If a small patient group is concerned, 
reimbursement for the treatment of this patient 
group should not be discontinued. 
+1 − 2 − 2 0 
26 − 1 − 1 − 2 − 3c  
Table 2 (continued ) 
# Statement F1a F2a F3a F4a 
If a condition is stressful for the patients’ 
family, reimbursement for its treatment should 
not be discontinued. 
27 If a contagious condition is concerned, 
reimbursement for its treatment should not be 
discontinued. 
+1 +2 +3 0 
28 If the treatment improves patients’ 
participation in society, its reimbursement 
should not be discontinued. 
+1c +3 0c +3 
29 If the reimbursement of a treatment is 
discontinued, patients who are already being 
treated with this treatment should still have it 
reimbursed. 
0b +1b 0b +1b 
30 If there is no support in society for 
discontinuing reimbursement of the treatment, 
the reimbursement should not be discontinued. 
0 +3c − 1 − 2c 
31 If a disproportionately large part of the care 
budget is spent on the treatment, its 
reimbursement may be discontinued. 
− 3c − 1 − 2 +1c 
32 If the care is organized in such a way that the 
treatment cannot be offered safely, its 
reimbursement may be discontinued. 
− 1 − 2 +1 +1 
33 When deciding to discontinue reimbursement, 
the same criteria should always be applied in 
the same manner. 
− 2 − 2 +1c +4c 
34 When deciding to discontinue reimbursement, 
it should always be made clear how and based 
on which criteria the decision was made. 
0c +2 +1 +3c 
35 If the discontinuation of the reimbursement of 
the treatment disproportionately affects a 
certain group of people in society, this 
reimbursement should not be discontinued. 
+1 +1 − 2c +1 
36 If the discontinuation of the reimbursement of 
the treatment concerns a vulnerable group in 
society, this reimbursement should not be 
discontinued. 
+1 +2 − 3 − 1 
37 When it comes to treatment of a life- 
threatening condition in young people, 
reimbursement should not be discontinued. 
+3 − 1c +3 +1c 
38 Because it is impossible to express a human life 
in terms of money, costs should not play a role 
in decisions about discontinuing 
reimbursement. 
+1c +3c − 3 − 3 
39 When it comes to care for patients who have a 
short time left to live, reimbursement of this 
care should not be discontinued 
0 0 − 1 − 1 
40 It is morally wrong to deny patients existing 
treatment. 
+2c − 4c − 2 − 1 
41 If the treatment can prevent people from 
becoming ill, its reimbursement should not be 
discontinued. 
+2 +1 +2 +2 
42 If the costs of the treatment per patient are 
high, reimbursement may be discontinued 
− 4c 0 − 1 − 1 
43 If the healthcare provider has not yet recouped 
its investment in the treatment, its 
reimbursement should not be discontinued. 
− 2 − 3 − 4c − 1c  
a The numbers displayed in these columns represent the factor score of each 
statement in each factor. This score indicates the column of the sorting grid 
(Fig. 1) where the statement would be placed if it would be sorted by a person 
with the particular view corresponding with the factor, with − 4 indicating the 
most left column (least agree), 0 indicating the middle column and +4 indicating 
the most right column (most agree). 
b Consensus statement (no difference between factors at a p-value <0.05). 
c Distinguishing statement (p-value <0.05). 
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+4): “If there are medical reasons that have been determined by a doctor, this 
should always be reimbursed!” (ID-33). Such treatments should remain in 
the basic benefits package, even if these only result in small health gains 
(#2, − 3*; #7, − 3) or in a low quality of life after treatment (#3, − 4*). 
People holding this viewpoint consider it morally wrong to deny pa-
tients an existing treatment (#40, +2*), in particular if no alternative 
treatment is available to patients (#24, +3), as is illustrated by the 
following quote: “As the text [statement] indicates. From a moral point of 
view, I do not think it is acceptable to deny existing treatment for any reason 
whatsoever (probably financial reasons).” (ID-01) People holding this 
viewpoint believe that the costs (#42,-4*), cost-effectiveness (#31, − 3*) 
and budget-impact (#31, − 3*) of treatments should not play any role in 
disinvestment decisions, as is illustrated by the following quotes: “That 
people get the care they need, no matter what it costs.” (ID-01); “Denying the 
right/necessary care should not be allowed. The country is prosperous enough 
to be able to offer this to every citizen.” (ID-20) For further reference, we 
will call this viewpoint “Maintain necessary healthcare, even if it is 
expensive or only results in small health gains”. 
3.2. Viewpoint II 
Similar to people holding viewpoint I, people holding this viewpoint 
believe that the reimbursement of necessary care (i.e. treatments that 
are medically necessary or are the only treatment option available) 
should be maintained (#24, +4; #15, +4*), irrespective of its costs 
(#38, +3*): “Care should be accessible to everyone, especially if it is 
medically necessary.” (ID-07) However, they believe necessity should be 
objectively determined and not, for example, based on insufficient sci-
entific evidence (#9, − 4*) or patient opinion (#18, − 3): “Most important 
is if the treatment does not work after thorough study.” (ID-21) Further-
more, they believe that if quality of life remains low after treatment (#3, 
+2*), if providers have not earned back their investment (#43, − 3), and 
if people can pay for their own treatment (#20, +2*) reimbursement 
may be stopped: “The costs of care are so high that the premium system 
should be changed. Wealthy people can then pay more and the socially 
disadvantaged can pay less.” (ID-21) Hence, they believe that in some 
situations, denying patients treatment is not morally wrong (40, − 4*). 
Furthermore, what is distinguishing for this viewpoint, is the importance 
attached to public support for disinvestment decisions. If there is no 
public support for stopping the reimbursement of healthcare, reim-
bursement should be maintained (#30, +3*): “Everyone is entitled to care 
if there is no support [for stopping reimbursement].” (I08) Also dis-
tinguishing for this viewpoint is the importance attached to participa-
tion in society and protecting vulnerable groups in society: when 
treatment contributes to patients being able to participate in society 
(#28, +3), or if stopping treatment would affect a vulnerable group 
(#36, +2), reimbursement should be maintained. For further reference, 
we call this viewpoint “Maintain necessary healthcare, if objectively 
determined and if there is no support for disinvestment”. 
3.3. Viewpoint III 
People holding this viewpoint consider it important to spend the 
healthcare budget in a well-considered way. Therefore, they think that 
the reimbursement of healthcare that is not necessary or that does not 
have any effect can be stopped (#19, +4*; #22, +4*; #4, +2): “Everyone 
has aches and pains sometimes. The idea is not that you need immediate care 
for every little ache and pain (that is part of normal life). This is at the 
expense of the people who really need care.” (ID-04); “There can be all kinds 
of reasons to deny patients existing treatments. Maybe a specific treatment 
does not work in their case, or the improvement in health would not outweigh 
the suffering that this treatment entails. So it is not morally wrong, but there 
has to be a logical reason for denying a patient certain treatment.” (ID-36) 
Furthermore, the reimbursement of healthcare that is not effective (#8, 
+2*) or not cost-effective can be stopped as well (#14, +3; #38, − 3*; 
#13, +1*): “From a business point of view, it is right to make a financial 
consideration. If it can be done more cheaply with the same desired effect, 
then I think that’s right.” (ID-26) Whether disinvestment affects a 
vulnerable group or any other group in society disproportionally should 
not be taken into account in disinvestment decisions (#35, − 2*; #36, 
− 3). If a treatment would prevent other people from becoming ill (#41, 
+2), is targeted at contagious diseases (#27, +3) or concerns a life- 
threatening disease in younger people (#37, +3), than that would be 
a good use of the healthcare budget and, hence, reimbursement can be 
maintained. People holding this viewpoint think that the patients’ voice 
should not play a role in disinvestment decisions. Whether patients feel 
they benefit from treatment or consider the treatment necessary is not 
relevant (#18, − 4*; #12, − 3*): “I think the doctor or hospital should 
decide that, and not the patients themselves.” (ID-15) Furthermore, people 
holding this viewpoint disagreed most with the statement that treatment 
should remain reimbursed until healthcare providers earned back their 
investment (#43, − 4*): “Nonsense, the composition of the basic health 
insurance package should never serve to balance the cash book of the phar-
maceutical industry. This industry is already doing enough itself, with that 
argument to raise prices absurdly.” (ID-41) For further reference, we call 
this viewpoint “Disinvest unnecessary, ineffective and inefficient 
healthcare”. 
3.4. Viewpoint IV 
People holding this viewpoint consider it important that disinvest-
ment decision-making (i.e. both the process and the considerations un-
derlying the decision) is transparent and consistent. If reimbursement 
for a certain treatment is stopped, it should be clearly explained why 
(#34, +3*). Furthermore, disinvestment decisions should always be 
based on the same set of criteria (#33, +4*). Why transparency and 
consistency are considered important is explained in the following 
quotes: “Because everyone should receive the same treatment and opportu-
nities.” (ID-29); “Then it’s easier to understand why the decision to dis-
continue it [reimbursement] has been taken.” (ID-29). 
In this view, effectiveness (#1, +4*) and medical necessity (#15, 
+3) are important criteria for care to remain reimbursed, particularly if 
it helps people to better function in society (#28, +3). However, the 
sustainability of the healthcare system is also a matter of concern: “The 
sustainability of the care system is very important and this means that the 
right balance must be found between good healthcare and financial sustain-
ability. One should not lose sight of the financial picture.” (ID-12) There-
fore, the costs and budget-impact of a treatment should be considered as 
well (#31, +1*, #38, − 3): “Discontinuation may be possible when costs are 
unnecessarily high and the same result is achieved with other cheaper 
means.” (ID-38). 
If disinvestment decisions are made in a transparent and consistent 
way, (a lack of) public support (#30, − 2*), patient preferences (#18, 
− 3*), the burden of the disease on the patient (#16, − 1) and the pa-
tient’s family (#26, − 3*), or whether people can pay for the treatment 
themselves (#20, − 4*) should not lead to exceptions to the rules. Also, 
whether a complaint is part of normal life should not play a role in 
disinvestment decision-making (#19, − 4), because this cannot be 
determined in a clear-cut, consistent manner. For further reference, this 
viewpoint is described as “Transparent and consistent disinvestment 
decision-making processes”. 
4. Discussion 
The aim of this study was to explore the societal viewpoints in the 
Netherlands on the active disinvestment of healthcare interventions and 
to identify the considerations that people holding these viewpoints find 
relevant in this context. Four distinct viewpoints were identified, which 
can be shortly described as: 1) Maintain reimbursement of necessary 
healthcare, even if it is expensive or only results in small health gains; 2) 
Maintain reimbursement of necessary healthcare, if objectively deter-
mined or if there is no public support for disinvestment; 3) Disinvest 
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unnecessary, ineffective or inefficient healthcare; and 4) It is most 
important that disinvestment decision-making processes are transparent 
and consistent. 
4.1. Comparison of our findings with the disinvestment literature 
There are several similarities between the findings of the three pre-
vious studies on relevant considerations in the context of disinvestment 
and some of the viewpoints identified in our current study. For instance, 
in our current study, we found that people holding viewpoint 4 consider 
it important that disinvestment decision-making processes are trans-
parent and consistent. This seems to confirm the finding of Bentley et al. 
that citizens consider it important that disinvestment decisions are 
based on clear and consistent principles (Bentley et al., 2019) and the 
finding of Coast et al. that people consider it important that disinvest-
ment decisions are transparent (Coast, 2001). Furthermore, some of the 
relevant considerations identified by Street et al. (2015) are supported 
by some of the viewpoints identified in our study. For instance, taking 
costs and effectiveness into account in disinvestment decisions is sup-
ported by viewpoints 3 and 4. Moreover, taking the availability of 
alternative treatments into account is supported by viewpoints 1 and 2. 
However, it becomes clear from our current study that these consider-
ations are not supported by all viewpoints, indicating that it is important 
to take heterogeneity in citizens’ viewpoints into account. 
Secondly, there are also some differences between the findings of 
previous studies and the findings of the current study. For instance, 
although Costa et al. found that citizens are reluctant to disrupt treat-
ment of current patients (Costa et al., 2019), this is not supported by any 
of the viewpoints identified in our current study: Statement 29 on 
continuing reimbursement for current patients was ranked in the middle 
of the distribution for all viewpoints. Even though this does not neces-
sarily mean that all participants sorted this statement in the middle of 
the sorting grid (i.e. agrees and disagrees among people holding the 
viewpoints may also cancel each other out for this statement), it does 
mean that in our current study we did not identify any viewpoint that 
found this consideration relatively important compared to the other 
considerations. 
4.2. Comparison of our findings with the decision criteria currently used 
in Dutch policy 
In the Netherlands, the National Healthcare Institute uses the four 
criteria effectiveness, cost-effectiveness, necessity and feasibility to 
advise the Ministry on the reimbursement of healthcare interventions. 
With regards to investment decisions, effectiveness is a ‘knock-out’ cri-
terion (Zwaap, 2017). However, our study shows that support for 
effectiveness as a criterion for disinvestment decisions varies. People 
holding viewpoint 1 consider effectiveness relatively unimportant, 
while people holding viewpoint 2 rank these considerations in the 
middle of the sorting grid, and people holding viewpoints 3 or 4 consider 
effectiveness relatively important. A similar pattern can be observed for 
the cost-effectiveness criterion: people holding viewpoint 1 or 2 think 
cost-effectiveness should not play a role, while people holding viewpoint 
3 or 4 consider this criterion important. However, there seems to be 
some consensus on the importance of the medical necessity criterion: 
statement 15 on medical necessity is located in the most agree tail of the 
distribution for all viewpoints (+4, +3, +2, +4). Nonetheless, there 
seem to be some differences between the viewpoints on the conse-
quences this criterion should have: people with viewpoint 1 or 2 
generally do not see a lack of medical necessity as a reason to disinvest 
an intervention or service, while people holding viewpoint 3 or 4 indi-
cate that non-necessary care should be disinvested. Furthermore, from 
the factor arrays some differences with regards to the interpretation of 
medical necessity can be observed. For instance, people holding view-
point 2, 3 or 4 generally do not agree with taking the patient’s opinion 
on necessity into account (statement 18), while people holding 
viewpoint 1 are more open to this. Moreover, while people holding 
viewpoint 3 think that treatments for illnesses that are part of normal life 
should be disinvested (statement 19), people holding viewpoint 4 do not 
agree with this (as this cannot be determined in a clear-cut way) and 
people holding viewpoint 1 or 2 are more neutral with regards to this 
statement. Finally, there is no consensus on the relative importance of 
the feasibility considerations budget-impact and public support, 
included in this study. Viewpoint 3 and 4 support the use of 
budget-impact as a criterion in disinvestment decisions, while viewpoint 
1 does not support this and viewpoint 2 is neutral. Furthermore, view-
point 2 considers public support very important, while viewpoint 1 does 
not seem to have a strong opinion on this and viewpoint 3 and 4 do not 
consider it to be important. 
4.3. Methodological considerations 
The use of Q-methodology in this study allowed us to obtain rich, 
holistic descriptions of the existing societal viewpoints on active disin-
vestment in the Netherlands (van Exel et al., 2015). Because of the 
combination of qualitative and quantitative research methods used in 
Q-methodology, it provided us with the opportunity to obtain in-depth 
insights in the existing viewpoints which are discerned in a systematic 
way. 
However, Q-methodology also has three disadvantages compared to 
other research methods. Firstly, because of the structured way of data 
collection, by asking all participants to sort the same set of statements 
with the same instruction, it could be argued that Q-methodology is not 
able to obtain such rich insights as non-structured or semi-structured 
qualitative research methods can. However, the statement set used in 
this study was based on the findings of our previous study in which we 
obtained in-depth insight in the considerations that may be relevant in 
disinvestment decisions through a large number of semi-structured in-
terviews (Rotteveel et al., 2021). Subsequently, the statement set was 
carefully developed and pilot-tested to ensure that the statements would 
cover the variety of aspects relevant in active disinvestment. After fin-
ishing statement sorting, participants had the opportunity to phrase 
their opinion. This process enabled us to evaluate whether any relevant 
aspect was missing. In this process no missing aspects were identified, 
indicating that all considerations relevant in the context of disinvest-
ment were included in this study. 
Secondly, because of the purposive sampling method, Q-methodol-
ogy is not suited to examine how the different viewpoints are distributed 
across society and whether the viewpoints are statistically significantly 
associated with any socio-demographic characteristics (Baker et al., 
2006; Mason et al., 2016). Survey approaches allowing a large number 
of probabilistically sampled participants to rate their agreement with 
aspects of the viewpoints (e.g. a selection of statements that discriminate 
best between viewpoints or short viewpoint descriptions) are more 
appropriate for this purpose (Baker et al., 2010; Mason et al., 2016). 
Finally, Q-methodology is also not the appropriate method to mea-
sure the relative strength of the preferences for the different consider-
ations in disinvestment decision-making. For this purpose, choice 
experiments would be more suitable. The characterizing and dis-
tinguishing statements identified in this study can serve as input for 
attribute development in future choice experiments. 
4.4. Strengths and limitations 
To our knowledge, this is the first Q-methodology study examining 
the societal views on the active disinvestment of healthcare in-
terventions. We ensured reliability of statement set development and 
viewpoint interpretation by conducting the development of the set of 
statements as well as the interpretation of the viewpoints with three 
researchers (i.e. triangulation) (Mays and Pope, 1995). Furthermore, 
pilot testing of the study materials and the face-to-face approach to data 
collection ensured reliability of data collection (Watts and Stenner, 
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2012). 
Despite these strengths, the current study also has some additional 
limitations to the ones described in section 4.3. Firstly, as for efficiency 
reasons the data were collected in groups, participants’ explanations of 
statement sortings were collected using a questionnaire. This resulted in 
short, written explanations of participants’ viewpoints. To ensure that 
the researchers would interpret these short explanations correctly, 
questionnaire responses were checked during the group sessions and any 
written clarification of the responses was requested if necessary. Despite 
this precaution, some nuances in viewpoint interpretation may have 
been overlooked due to the short, written viewpoint explanations pro-
vided by participants. 
Secondly, this study has been conducted in a Dutch setting. As 
disinvestment processes are considered context-specific (MacKean et al., 
2013), researchers and policymakers are recommended to take the 
context into account when considering the implications of the results of 
this study in their context. However, as a previous Q-methodology study 
assessing allocation preferences in the investment context in nine Eu-
ropean countries (i.e. Denmark, France, Hungary, the Netherlands, 
Norway, Poland, Spain, Sweden and the UK) only found small differ-
ences in the views between these countries (van Exel et al., 2015), we 
believe that the views identified in this study are also broadly applicable 
to other (European) contexts. 
4.5. Policy implications 
Active disinvestment has been described as a delicate issue (MacK-
ean et al., 2013), with public support being considered essential for its 
success (Daniels et al., 2013). Even though it is also part of a policy-
maker’s job to make unpopular decisions, such as disinvestment de-
cisions, public support may increase the success of such decisions. The 
results of this study show considerable heterogeneity between groups in 
society in their views on disinvestment and in the considerations they 
consider relevant in this context. This indicates that it will be very 
difficult, if not impossible, to design the disinvestment process and 
corresponding communication in such a way that the preferences of all 
people holding the different viewpoints will be met. Hence, it indicates 
that it is very difficult to obtain support for disinvestment from all 
groups in society. 
However, despite the identified heterogeneity between the view-
points, the results of this study also provide policymakers with guidance 
on how to increase public support for disinvestment. Firstly, our study 
shows that all four viewpoints support the use of medical necessity as a 
consideration in disinvestment decisions. Therefore, in selecting candi-
date interventions for disinvestment and in the communication on 
disinvestment decisions, we recommend policymakers to focus on 
medical necessity. However, the interpretation and consequences 
attached to this criterion differ between viewpoints, possibly explaining 
the broad support for this statement. Despite of this, people from all 
viewpoints seem to support necessity as has been determined by 
healthcare professionals as a way to determine what medical necessity 
is. Therefore, policymakers are recommended to focus on this inter-
pretation of medical necessity. Although people holding viewpoint 1 and 
2 support medical necessity as a criterion, they only seem to see medical 
necessity as a reason to reimburse treatments, not as a reason to disin-
vest treatments. Therefore, to also increase support among people 
holding viewpoint 1 or 2, policymakers are recommended to put 
emphasis on the fact that disinvestment of non-necessary healthcare will 
create scope for the reimbursement of necessary healthcare. 
Secondly, our study shows that people holding viewpoint 4 consider 
a transparent disinvestment process very important. Although trans-
parency is less important for those holding the other viewpoints, these 
people still place this statement on the most agree side of the sorting 
grid, indicating that, to some degree, they agree with this statement. 
Therefore, we recommend policymakers to improve the transparency of 
the disinvestment process and corresponding communication to 
increase support from people holding viewpoint 4 and from people 
holding the other viewpoints as well. 
5. Conclusion 
In conclusion, this study shows that there are four distinct societal 
viewpoints on active disinvestment of publicly funded health technol-
ogies that highlight important considerations for decision-making in this 
context. Insight in these viewpoints can thus help policymakers to better 
understand why it has been considered difficult to obtain public support 
for disinvestment, and how this can perhaps be improved in the future. 
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